國立虎尾科技大學 |

Hepatocellular Carcinoma = Translational Precision Medicine Approaches /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Hepatocellular Carcinoma/ edited by Yujin Hoshida.
其他題名:	Translational Precision Medicine Approaches /
其他作者:	Hoshida, Yujin.
面頁冊數:	XV, 364 p. 56 illus., 37 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Pathology. -
電子資源:	https://doi.org/10.1007/978-3-030-21540-8
ISBN:	9783030215408

Hepatocellular Carcinoma = Translational Precision Medicine Approaches /
Hepatocellular CarcinomaTranslational Precision Medicine Approaches /[electronic resource] :edited by Yujin Hoshida. - 1st ed. 2019. - XV, 364 p. 56 illus., 37 illus. in color.online resource. - Molecular and Translational Medicine,2197-7852. - Molecular and Translational Medicine,.

Part 1: Clinical demographics and management -- 1. Risk Factors of Hepatocellular Carcinoma for Precision Personalized Care -- 2. Hepatocellular Carcinoma Surveillance and Staging -- 3. Changing Epidemiology of Hepatocellular Carcinoma and Role of Surveillance -- Part 2: Diagnosis and prognostication -- 4. Radiological diagnosis and characterization of HCC -- 5. Analysis of Hepatocellular Carcinoma Tissue for Biomarker and Therapeutic Target Discovery -- 6. Molecular subtypes and genomic signatures of hepatocellular carcinoma for prognostication and therapeutic decision making -- 7. Liquid Biopsy in Hepatocellular Carcinoma -- Part 3: Treatment -- 8. Surgical Therapies in Hepatocellular Carcinoma -- 9. Interventional Radiologic Therapies for Hepatocellular Carcinoma: From Where We Began To Where We Are Going -- 10. Precision Locoregional Therapies for Hepatocellular Carcinoma: Percutaneous Ablation and Radiotherapy -- 11. Molecular-targeted therapies in hepatocellular carcinoma -- 12. Immune therapies -- 13. Prevention Strategies for Hepatocellular Carcinoma -- Part 4: Molecular pathogenesis and therapeutic discovery -- 14. Molecular Alterations and Heterogeneity in Hepatocellular Carcinoma -- 15. Stromal and Immune Drivers of Hepatocarcinogenesis -- 16. Experimental Models for Preclinical Research in Hepatocellular Carcinoma.

This book provides a comprehensive overview of the current limitations and unmet needs in Hepatocellular Carcinoma (HCC) diagnosis, treatment, and prevention. It also provides newly emerging concepts, approaches, and technologies to address challenges. Topics covered include changing landscape of HCC etiologies in association with health disparities, framework of clinical management algorithm, new and experimental modalities of HCC diagnosis and prognostication, multidisciplinary treatment options including rapidly evolving molecular targeted therapies and immune therapies, multi-omics molecular characterization, and clinically relevant experimental models. The book is intended to assist collaboration between the diverse disciplines and facilitate forward and reverse translation between basic and clinical research by providing a comprehensive overview of relevant areas, covering epidemiological trend and population-level patient management strategies, new diagnostic and prognostic tools, recent advances in the standard care and novel therapeutic approaches, and new concepts in pathogenesis and experimental approaches and tools, by experts and opinion leaders in their respective fields. By thoroughly and concisely covering whole aspects of HCC care, Hepatocellular Carcinoma serves as a valuable reference for multidisciplinary readers, and promotes the development of personalized precision care strategies that lead to substantial improvement of disease burden and patient prognosis in HCC.

ISBN: 9783030215408

Standard No.: 10.1007/978-3-030-21540-8doiSubjects--Topical Terms:

668553
Pathology.

LC Class. No.: RB1-214

Dewey Class. No.: 616.07

Hepatocellular Carcinoma = Translational Precision Medicine Approaches /
LDR:04268nam a22004095i 4500 001 1003853
003 DE-He213
005 20200702122749.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783030215408 $9 978-3-030-21540-8
024 7 $a 10.1007/978-3-030-21540-8 $2 doi
035 $a 978-3-030-21540-8
050 4 $a RB1-214
072 7 $a MMF $2 bicssc
072 7 $a MED067000 $2 bisacsh
072 7 $a MKF $2 thema
082 0 4 $a 616.07 $2 23
245 1 0 $a Hepatocellular Carcinoma $h [electronic resource] : $b Translational Precision Medicine Approaches / $c edited by Yujin Hoshida.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Humana, $c 2019.
300 $a XV, 364 p. 56 illus., 37 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Molecular and Translational Medicine, $x 2197-7852
505 0 $a Part 1: Clinical demographics and management -- 1. Risk Factors of Hepatocellular Carcinoma for Precision Personalized Care -- 2. Hepatocellular Carcinoma Surveillance and Staging -- 3. Changing Epidemiology of Hepatocellular Carcinoma and Role of Surveillance -- Part 2: Diagnosis and prognostication -- 4. Radiological diagnosis and characterization of HCC -- 5. Analysis of Hepatocellular Carcinoma Tissue for Biomarker and Therapeutic Target Discovery -- 6. Molecular subtypes and genomic signatures of hepatocellular carcinoma for prognostication and therapeutic decision making -- 7. Liquid Biopsy in Hepatocellular Carcinoma -- Part 3: Treatment -- 8. Surgical Therapies in Hepatocellular Carcinoma -- 9. Interventional Radiologic Therapies for Hepatocellular Carcinoma: From Where We Began To Where We Are Going -- 10. Precision Locoregional Therapies for Hepatocellular Carcinoma: Percutaneous Ablation and Radiotherapy -- 11. Molecular-targeted therapies in hepatocellular carcinoma -- 12. Immune therapies -- 13. Prevention Strategies for Hepatocellular Carcinoma -- Part 4: Molecular pathogenesis and therapeutic discovery -- 14. Molecular Alterations and Heterogeneity in Hepatocellular Carcinoma -- 15. Stromal and Immune Drivers of Hepatocarcinogenesis -- 16. Experimental Models for Preclinical Research in Hepatocellular Carcinoma.
520 $a This book provides a comprehensive overview of the current limitations and unmet needs in Hepatocellular Carcinoma (HCC) diagnosis, treatment, and prevention. It also provides newly emerging concepts, approaches, and technologies to address challenges. Topics covered include changing landscape of HCC etiologies in association with health disparities, framework of clinical management algorithm, new and experimental modalities of HCC diagnosis and prognostication, multidisciplinary treatment options including rapidly evolving molecular targeted therapies and immune therapies, multi-omics molecular characterization, and clinically relevant experimental models. The book is intended to assist collaboration between the diverse disciplines and facilitate forward and reverse translation between basic and clinical research by providing a comprehensive overview of relevant areas, covering epidemiological trend and population-level patient management strategies, new diagnostic and prognostic tools, recent advances in the standard care and novel therapeutic approaches, and new concepts in pathogenesis and experimental approaches and tools, by experts and opinion leaders in their respective fields. By thoroughly and concisely covering whole aspects of HCC care, Hepatocellular Carcinoma serves as a valuable reference for multidisciplinary readers, and promotes the development of personalized precision care strategies that lead to substantial improvement of disease burden and patient prognosis in HCC.
650 0 $a Pathology. $3 668553
650 0 $a Oncology . $3 1253469
650 0 $a Gastroenterology . $3 1254565
650 0 $a Hepatology. $3 673859
650 2 4 $a Oncology. $3 593951
650 2 4 $a Gastroenterology. $3 673684
700 1 $a Hoshida, Yujin. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1297209
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030215392
776 0 8 $i Printed edition: $z 9783030215415
776 0 8 $i Printed edition: $z 9783030215422
830 0 $a Molecular and Translational Medicine, $x 2197-7852 $3 1255156
856 4 0 $u https://doi.org/10.1007/978-3-030-21540-8
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)